1. Department of Experimental Oncology, Cross Cancer Institute, and Department of Oncology, University of Alberta, Edmonton, Alberta T6G 1Z2, Canada, and Genome Damage and Stability Centre, University of Sussex, Science Park Road, Falmer, Brighton BN1 9RQ, U.K.